Pharmacies enjoyed a temporary spate of attractive prices on parallel imports during April and May. The conclusion to be drawn from this is that dispensing GP PI offers do seem to be decided on a case-by-case basis; as a result the graph of historical data for dispensing doctor PI prices is more erratic than that for pharmacy PI prices.
However, dispensing doctors continue to hold the upper hand and achieve the best prices for generics, even though generic price setting is even more erratic and time dependent than that for PIs.
In terms of the headliners for May, among the risers are four packs each of amisulpride and lamotrigine tabs, three packs of buprenorphine sublingual tabs and rivastigmine caps, and one of tadalafil tabs. Two packs of tadalafil tabs are also among the fallers, alongside four packs of rosuvastatin tabs.
To view the full analysis and the Wavedata spreadsheet, DDA members can visit the online library of purchase price analyses.